Menstrual Cycle · Premenstrual Disorders
Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial
Cite this paper
Tully, L., Humiston, J., & Cash, A. (2020). Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial. Obstetrics & Gynecology Science, 63(2), 195-204. https://doi.org/10.5468/ogs.2020.63.2.195
Tully L, Humiston J, Cash A. Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial. Obstet Gynecol Sci. 2020;63(2):195-204. doi:10.5468/ogs.2020.63.2.195
Tully, Lisa, et al. "Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial." Obstetrics & Gynecology Science, vol. 63, no. 2, 2020, pp. 195-204.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
Free full text on PubMed Central (PMC7073356)
Author affiliations
3 institutions- US Biologic (United States)
04mdfaw94
- The Center for Health and Wellbeing, San Diego, CA, USA.
- Nutritional Supplements Division, Energy Medicine Research Institute, Boulder, CO, USA.
Linked to ROR, the Research Organization Registry


